Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk of Migraine in Patients With Asthma: A Nationwide Cohort Study.

Medicine·2016

Same author

Association Between Kidney Stones and Risk of Stroke: A Nationwide Population-Based Cohort Study.

Medicine·2016

Same author

Increased Risk of Stroke in Patients With Fibromyalgia: A Population-BASED Cohort Study.

Medicine·2016

Same author

Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study.

Medicine·2016

Same author

Association of statin use and the risk of end-stage renal disease: A nationwide Asian population-based case-control study.

European journal of internal medicine·2016

Same author

Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study.

Inflammatory bowel diseases·2016

Search research articles

Related Experiment Video

Updated: May 21, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Estrogen decrease coronary artery disease risk in patients with cervical cancer after treatment.

Li-Min Sun¹, Ji-An Liang, Shih-Ni Chang

¹Department of Radiation Oncology, Zuoying Armed Forces General Hospital, Kaohsiung, Taiwan.

Gynecologic Oncology

|June 16, 2012

Summary

This study found that cervical cancer patients had a lower risk of coronary artery disease (CAD). Estrogen supplements were particularly associated with decreased CAD risk in this group.

Related Experiment Videos

Last Updated: May 21, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Area of Science:

Cardiovascular Health
Oncology
Epidemiology

Background:

Investigating the link between cervical cancer and coronary artery disease (CAD) risk is crucial for understanding patient comorbidities.
Previous research has not fully elucidated the association between these two conditions.

Purpose of the Study:

To explore the potential association between cervical cancer and the risk of developing coronary artery disease (CAD).

Main Methods:

Utilized Taiwan's National Health Insurance system data.
Included 728 cervical cancer patients and matched controls.
Employed Cox proportional hazard regression for risk analysis.

Main Results:

Cervical cancer patients exhibited a significantly lower overall risk of CAD (aHR: 0.57, 95% CI: 0.41-0.79).
This reduced risk was notable in older patients, those with shorter follow-up, and particularly those using estrogen supplements (aHR: 0.39, 95% CI: 0.22-0.68).

Conclusions:

Estrogen supplements are linked to a decreased CAD risk in cervical cancer patients.
This population-based study highlights a potential protective effect of estrogen in this specific cohort.